Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ITMN-191: Phase Ib start

This month, ITMN and ROG will begin the multiple-ascending dose Phase Ib MAD trial

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE